AI assistant
Sending…
Fagron N.V. — Capital/Financing Update 2017
Apr 30, 2017
3949_rns_2017-04-30_8cc19868-ceb0-4431-8fc7-decd15e81585.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
| FAGRON NV – 4.75 % fixed rate bonds due 2 July 2017 – date of issue 2 July 2012 (ISIN BE0002180462) Guarantor list in accordance with Article 10.4. (Guarantor list) of the Guarantee |
|||
|---|---|---|---|
| ACA PHARMA NV | a Belgian company with its registered seat at Venecoweg 20 A, 9810 Nazareth, company number 416.616.681, RPR Kortrijk |
Venecoweg 20 A, 9810 Nazareth, Belgium Att: Hans Stols, represented by Hans Stols, Director |
|
| ARSEUS BELGIE NV | a Belgian company with its registered seat at Venecoweg 20 A, 9810 Nazareth, company number 416.616.681, RPR Kortrijk |
Venecoweg 20 A, 9810 Nazareth, Belgium Att: Hans Stols, represented by Hans Stols, Director |
|
| ARSEUS CAPITAL NV | a Belgian company with its registered seat at Venecoweg 20 A, 9810 Nazareth, company number 416.616.681, RPR Kortrijk |
Venecoweg 20 A, 9810 Nazareth, Belgium Att: Hans Stols, represented by Hans Stols, Director |
|
| B&B PHARMACEUTICALS, INC. | a Colorado corporation, 17200 East Ohio Drive, Aurora, Colorado 80017, United States of America |
Venecoweg 20 A 9810 Nazareth, Belgium Att: Hans Stols |
|
| FAGRON NL B.V. | a Dutch company with its registered seat at Venkelbaan 101, 2908 KE Capelle aan den IJssel and registered in the trade register under number 24259311 |
Venkelbaan 101, 2908 KE Capelle aan den IJssel, The Netherlands Att: Fagron B.V., represented by Fagron B.V., represented by Hans Stols, Director |
|
| FAGRON, INC. | a Minnesota corporation, 2400 Pilot Knobroad, St. Paul, Minnesota, 55120, United States of America |
Fagron NV, Venecoweg 20 A 9810 Nazareth, Belgium Att: Hans Stols |
|
| FAGRON BELGIUM NV | a Belgian company with its registered seat at Venecoweg 20 A, 9810 Nazareth, company number 416.616.681, RPR Kortrijk |
Venecoweg 20 A, 9810 Nazareth, Belgium Att: Hans Stols, Director |
| FAGRON GMBH & CO KG | a German company with its registered seat at Von Bronsartstraβe 12, 22885 Barsbüttel, registered in the trade register (Handelsregister) of the court (Amtsgericht) of Lübeck under HRA 2157RE |
Von Bronsartstraβe 12, 22885, Barsbüttel, Germany Att: Hans Stols, Director |
|---|---|---|
| FREEDOM PHARMACEUTICALS, INC. | an Oklahoma corporation, 801 W. New Orleans Street, Broken Arrow, Oklahoma 74011, United States of America |
Fagron NV, Venecoweg 20 A 9810 Nazareth, Belgium Att: Hans Stols |
| PHARMA-COSMETIC K.M. ADAMOWICZ SP. Z.O.O. | a Polish company with registered office in Krakow | Adress: Pasternik 26, 31-354 Krakau, Poland Att: Hans Stols |
| FAGRON POLAND SP. Z.O.O. | a Polish company with registered office in Krakow | Adress: Pasternik 26, 31-354 Krakau, Poland Att: Hans Stols |
| SPRUYT-HILLEN B.V. | a Dutch company with its registered seat at Tinbergenlaan 1, 3401 MT IJsselstein and registered in the trade register under number 30091194 |
Tinbergenlaan 1, 3401 MT IJsselstein, The Netherlands Att: Fagron B.V., represented by Fagron B.V., represented by Hans Stols, Director |
| SM EMPREEDIMENTOS FARMACEUTICOS LTDA | CNPJ: 44.015.477/0001-16 | Rua Jurupari 775/779/803 - Jardim Oriental, 04348-070 São Paulo (Brasil) Att: Rafael Padilla Papaceit |
| STEUNPUNT APOTHEEK MIERLO-HOUT B.V. | a Dutch company registered with the Commercial Court under registration number 17083775 |
Venecoweg 20 A, 9810 Nazareth, Belgium Att: Hans Stols |
In the event of any discrepancy between the English translation and the original Dutch version of the Guarantor list, the latter shall prevail.
More from Fagron N.V.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Major Shareholding Notification
2026
May 18
Major Shareholding Notification
2026
May 18
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Declaration of Voting Results & Voting Rights Announcements
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 11
Regulatory Filings
2026
May 1
Regulatory Filings
2026
May 1